Agilent (A) Stock Forecast & Price Target

Compare

3,112 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

A Analyst Ratings

Moderate Buy

7 Buy

5 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Agilent

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

A Stock 12 Month Forecast

Average Price Target

$139.45

▲(10.04% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Agilent in the last 3 months. The average price target is $139.45 with a high forecast of $165.00 and a low forecast of $125.00. The average price target represents a 10.04% change from the last price of $126.73.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"105":"$105","166":"$166","120.25":"$120.3","135.5":"$135.5","150.75":"$150.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":165,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$165.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":139.45,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$139.45</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":125,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$125.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[105,120.25,135.5,150.75,166],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,125.21,128.27076923076922,131.33153846153846,134.3923076923077,137.4530769230769,140.51384615384615,143.57461538461538,146.63538461538462,149.69615384615383,152.75692307692307,155.8176923076923,158.87846153846152,161.93923076923076,{"y":165,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,125.21,126.30538461538461,127.40076923076923,128.49615384615385,129.59153846153845,130.68692307692308,131.78230769230768,132.87769230769229,133.97307692307692,135.06846153846152,136.16384615384615,137.25923076923075,138.35461538461539,{"y":139.45,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,125.21,125.19384615384615,125.1776923076923,125.16153846153846,125.14538461538461,125.12923076923076,125.11307692307692,125.09692307692308,125.08076923076923,125.06461538461538,125.04846153846154,125.0323076923077,125.01615384615384,{"y":125,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":141.83,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.67,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":136.04,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":138.73,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.77,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":150.88,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":127.38,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":113.81,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":106.24,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.82,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":120.45,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":113.5,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":125.21,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$165.00

Average Price Target$139.45

Lowest Price Target$125.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Daniel Brennan

TD Cowen

$150

Buy

18.36%

Upside

Reiterated

09/05/25

TD Cowen Keeps Their Buy Rating on Agilent (A)

Puneet Souda

Leerink Partners

$135→$140

Buy

10.47%

Upside

Reiterated

09/01/25

Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A) and Edwards Lifesciences (NYSE: EW)

Cira Diagnissa

TR | OpenAI - 4o

$136

Buy

7.31%

Upside

Reiterated

08/29/25

AI Generated ArticleAI Generated Article

Luke Sergott

Barclays

$125

Hold

-1.37%

Downside

Reiterated

08/29/25

Barclays Sticks to Their Hold Rating for Agilent (A)

Brandon Couillard

Wells Fargo

$135→$140

Buy

10.47%

Upside

Reiterated

08/28/25

Agilent price target raised to $140 from $135 at Wells FargoAgilent price target raised to $140 from $135 at Wells Fargo

Catherine Ramsey Schulte

Robert W. Baird

$141→$142

Buy

12.05%

Upside

Reiterated

08/28/25

Agilent price target raised to $142 from $141 at BairdAgilent price target raised to $142 from $141 at Baird

Patrick B Donnelly

Citi

$165

Buy

30.20%

Upside

Reiterated

08/28/25

Citi Reaffirms Their Buy Rating on Agilent (A)

Paul Knight

KeyBanc

―

Hold

―

Reiterated

08/28/25

KeyBanc Remains a Hold on Agilent (A)

Eve Burstein

Bernstein

$125

Hold

-1.37%

Downside

Reiterated

08/28/25

Agilent's Strong Revenue Growth Offset by Margin Concerns: Hold Rating Maintained

Vijay Kumar

Evercore ISI

$130→$128

Hold

1.00%

Upside

Reiterated

08/28/25

Evercore ISI Keeps Their Hold Rating on Agilent (A)

Rachel Vatnsdal

J.P. Morgan

$155

Buy

22.31%

Upside

Reiterated

08/28/25

J.P. Morgan Reaffirms Their Buy Rating on Agilent (A)

Michael Ryskin

Bank of America Securities

$128

Hold

1.00%

Upside

Reiterated

08/27/25

Agilent Technologies: Balancing Strong Growth with Tariff-Induced Margin Pressures - Hold Rating MaintainedWe update our model to reflect today’s print, but our PO remains unchanged (still $128, based on 18x CY26 Adj EBITDA). Key question is 2026 Street ests but we think Agilent numbers are in a good place. Valuation appears fair and we reiterate Neutral rating.

Tycho Peterson

Jefferies

$116→$120

Hold

-5.31%

Downside

Reiterated

05/29/25

Jefferies Sticks to Its Hold Rating for Agilent (A)

Liza Garcia

UBS

$150→$130

Hold

2.58%

Upside

Reiterated

05/29/25

Agilent (A) Gets a Hold from UBS

Daniel Arias

Stifel Nicolaus

$151

Buy

19.15%

Upside

Reiterated

05/29/25

Agilent's Strong Performance and Promising Outlook: A Buy Recommendation by Daniel Arias

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Daniel Brennan

TD Cowen

$150

Buy

18.36%

Upside

Reiterated

09/05/25

TD Cowen Keeps Their Buy Rating on Agilent (A)

Puneet Souda

Leerink Partners

$135→$140

Buy

10.47%

Upside

Reiterated

09/01/25

Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A) and Edwards Lifesciences (NYSE: EW)

Cira Diagnissa

TR | OpenAI - 4o

$136

Buy

7.31%

Upside

Reiterated

08/29/25

AI Generated ArticleAI Generated Article

Luke Sergott

Barclays

$125

Hold

-1.37%

Downside

Reiterated

08/29/25

Barclays Sticks to Their Hold Rating for Agilent (A)

Brandon Couillard

Wells Fargo

$135→$140

Buy

10.47%

Upside

Reiterated

08/28/25

Agilent price target raised to $140 from $135 at Wells FargoAgilent price target raised to $140 from $135 at Wells Fargo

Catherine Ramsey Schulte

Robert W. Baird

$141→$142

Buy

12.05%

Upside

Reiterated

08/28/25

Agilent price target raised to $142 from $141 at BairdAgilent price target raised to $142 from $141 at Baird

Patrick B Donnelly

Citi

$165

Buy

30.20%

Upside

Reiterated

08/28/25

Citi Reaffirms Their Buy Rating on Agilent (A)

Paul Knight

KeyBanc

―

Hold

―

Reiterated

08/28/25

KeyBanc Remains a Hold on Agilent (A)

Eve Burstein

Bernstein

$125

Hold

-1.37%

Downside

Reiterated

08/28/25

Agilent's Strong Revenue Growth Offset by Margin Concerns: Hold Rating Maintained

Vijay Kumar

Evercore ISI

$130→$128

Hold

1.00%

Upside

Reiterated

08/28/25

Evercore ISI Keeps Their Hold Rating on Agilent (A)

Rachel Vatnsdal

J.P. Morgan

$155

Buy

22.31%

Upside

Reiterated

08/28/25

J.P. Morgan Reaffirms Their Buy Rating on Agilent (A)

Michael Ryskin

Bank of America Securities

$128

Hold

1.00%

Upside

Reiterated

08/27/25

Tycho Peterson

Jefferies

$116→$120

Hold

-5.31%

Downside

Reiterated

05/29/25

Jefferies Sticks to Its Hold Rating for Agilent (A)

Liza Garcia

UBS

$150→$130

Hold

2.58%

Upside

Reiterated

05/29/25

Agilent (A) Gets a Hold from UBS

Daniel Arias

Stifel Nicolaus

$151

Buy

19.15%

Upside

Reiterated

05/29/25

Agilent's Strong Performance and Promising Outlook: A Buy Recommendation by Daniel Arias

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Agilent

1 Month

xxx

Success Rate

26/38 ratings generated profit

Average Return

+2.15%

reiterated a xxx

rating 16 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 68.42% of your transactions generating a profit, with an average return of +2.15% per trade.

3 Months

xxx

Success Rate

27/41 ratings generated profit

Average Return

+3.08%

reiterated a xxx

rating 16 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 65.85% of your transactions generating a profit, with an average return of +3.08% per trade.

1 Year

Brandon CouillardWells Fargo

Success Rate

29/38 ratings generated profit

Average Return

+17.36%

reiterated a buy rating 16 days ago

Copying Brandon Couillard's trades and holding each position for 1 Year would result in 76.32% of your transactions generating a profit, with an average return of +17.36% per trade.

2 Years

xxx

Success Rate

26/38 ratings generated profit

Average Return

+24.02%

reiterated a xxx

rating 16 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 68.42% of your transactions generating a profit, with an average return of +24.02% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

A Analyst Recommendation Trends

Rating

May 25

Jun 25

Jul 25

Aug 25

Sep 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, A has received 23 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. A average Analyst price target in the past 3 months is 139.45.

Each month's total comprises the sum of three months' worth of ratings.

A Financial Forecast

A Earnings Forecast

Next quarter’s earnings estimate for A is $1.58 with a range of $1.58 to $1.60. The previous quarter’s EPS was $1.37. A beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.16% of the time in the same period. In the last calendar year A has Outperformed its overall industry.

A Sales Forecast

Next quarter’s sales forecast for A is $1.83B with a range of $1.82B to $1.84B. The previous quarter’s sales results were $1.74B. A beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.17% of the time in the same period. In the last calendar year A has Outperformed its overall industry.

A Stock Forecast FAQ

What is A’s average 12-month price target, according to analysts?

Based on analyst ratings, Agilent Technologies’s 12-month average price target is 139.45.

What is A’s upside potential, based on the analysts’ average price target?

Agilent Technologies has 10.04% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is A a Buy, Sell or Hold?

Agilent Technologies has a consensus rating of Moderate Buy which is based on 7 buy ratings, 5 hold ratings and 0 sell ratings.

What is Agilent Technologies’s price target?

The average price target for Agilent Technologies is 139.45. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $165.00 ,the lowest forecast is $125.00. The average price target represents 10.04% Increase from the current price of $126.73.

What do analysts say about Agilent Technologies?

Agilent Technologies’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of A?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Agilent (A) Stock Forecast & Price Target

A Analyst Ratings

A Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Agilent

A Analyst Recommendation Trends

A Financial Forecast

A Earnings Forecast

A Sales Forecast

A Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts